WHO ICTRP trial
A prospective,single arm, open study of Mesylate Apatinib combined with FOLFOX…
ChiCTR1800014964 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800014964 |
|---|---|
| Public title | A prospective ,single arm, open study of Mesylate Apatinib combined with FOLFOX in the treatment of advanced colorectal cancer |
| Scientific title | A prospective ,single arm, open study of Mesylate Apatinib combined with FOLFOX in the treatment of advanced colorectal cancer |
| Primary sponsor | Affiliated Tumor Hospital of GuangXi Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Post-market |
| Countries | China |
| Conditions | colorectal cancer |
| Interventions | Case series:Mesylate Apatinib |
| Registration date | Feb 25, 2018 |
| Target size | Case series:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: